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Neuromuscular junction (NMJ) formation requires
agrin, a factor released from motoneurons, and
MuSK, a transmembrane tyrosine kinase that is acti-
vated by agrin. However, how signal is transduced
from agrin to MuSK remains unclear. We report that
LRP4, a low-density lipoprotein receptor (LDLR)-
related protein, is expressed specifically inmyotubes
and binds to neuronal agrin. Its expression enables
agrin binding and MuSK signaling in cells that other-
wise do not respond to agrin. Suppression of LRP4
expression in muscle cells attenuates agrin binding,
agrin-induced MuSK tyrosine phosphorylation, and
AChR clustering. LRP4 also forms a complex with
MuSK in a manner that is stimulated by agrin. Finally,
we showed that LRP4 becomes tyrosine-phosphory-
lated in agrin-stimulated muscle cells. These obser-
vations indicate that LRP4 is a coreceptor of agrin
that is necessary for MuSK signaling and AChR clus-
tering and identify a potential target protein whose
mutation and/or autoimmunization may cause mus-
cular dystrophies.
INTRODUCTION
The neuromuscular junction (NMJ) is a cholinergic synapse that
conveys signals from motor neurons to muscle cells. It has
served as an informative model of synaptogenesis because of
its simplicity and accessibility (Sanes and Lichtman, 1999, 2001).
NMJ formation requires communication between presynaptic
motor neurons and postsynaptic muscle fibers (Brandon et al.,
2003; Fu et al., 2008; Li et al., 2008; Sanes and Lichtman,
2001). Agrin is a main nerve-derived organizer of postsynaptic
differentiation at the NMJ (McMahan, 1990). Mice lacking agrin
displayed severe deficits in NMJ formation (Gautam et al.,
1996). Introduction of agrin into denervated muscles elicits for-
mation of postsynaptic apparatus (Bezakova et al., 2001; Gese-
mann et al., 1995; Herbst and Burden, 2000; Jones et al., 1997).
MuSK is a component of the agrin receptor complex (DeChiara
et al., 1996; Jennings et al., 1993; Lin et al., 2001; Valenzuela
et al., 1995; Yang et al., 2001). MuSK mutant mice do not formthe NMJ and prepattern of aneuronal AChR-rich sites in the
central region (Kim and Burden, 2008; Lin et al., 2001; Yang
et al., 2001). Moreover, agrin induces rapid tyrosine phosphory-
lation ofMuSK in culturedmuscle cells (Glass et al., 1996a). Agrin
is no longer able to induce AChR clusters inMuSK/myotubes
and the agrin sensitivity can be restored by the introduction of
wild-type MuSK (Glass et al., 1996a; Zhou et al., 1999). These
observations provide evidence that agrin functions by stimulat-
ing MuSK. A fundamental gap in our understanding of agrin/
MuSK signaling, despite its essential role in NMJ formation
and maintenance (Hesser et al., 2006; Kim and Burden, 2008),
is how signals are transmitted from agrin to MuSK, because the
two proteins do not interact directly (Glass et al., 1996a). A hypo-
thetical molecule, myotube-associated specificity component
(MASC), was proposed to serve as a binding partner for agrin
to transduce signals to MuSK (Glass et al., 1996a). Despite ex-
tensive studies, the identity of this coreceptor of agrin remains
unclear.
LRP4 (or MEGF7, for multiple epidermal growth factor [EGF]-
like domain 7) is a member of the LDLR family, and contains
a large extracellular N-terminal region that possesses multiple
EGF repeats and LDLR repeats, a transmembrane domain, and
a short C-terminal region without an identifiable catalytic motif
(Johnson et al., 2005; Lu et al., 2007; Tian et al., 2006; Yamaguchi
et al., 2006). Its partial clone was identified by a motif trap screen
of genes encoding proteins with multiple EGF domains (Na-
kayama et al., 1998). Remarkably, LRP4 is required for NMJ for-
mation as well as the development of the limb, lung, kidney, and
ectodermal organs (Johnson et al., 2005; Simon-Chazottes et al.,
2006; Weatherbee et al., 2006). Mice lacking LRP4 die at birth
with deficits that resemble the phenotype observed inMuSKmu-
tant mice (Weatherbee et al., 2006). The phenotypic similarity
suggested that LRP4 plays a role inMuSK signaling (Weatherbee
et al., 2006). However, molecular mechanisms of how LRP4
regulates NMJ formation remain unclear.
Here we provide evidences that LRP4 functions as a corecep-
tor of agrin. LRP4 is expressed specifically in myotubes and is
concentrated at theNMJ. The extracellular domain of LRP4binds
to neuronal, but not muscle, agrin. LRP4 also interacts with
MuSK in a manner enhanced by agrin. Suppression of LRP4 ex-
pression attenuated agrin binding activity, agrin-induced MuSK
tyrosine phosphorylation, and AChR clustering in muscle cells.
LRP4 expression, on the other hand, reconstitutes agrin binding
and MuSK activation by agrin in cells that would otherwise notNeuron 60, 285–297, October 23, 2008 ª2008 Elsevier Inc. 285
Neuron
LRP4 as an Agrin CoreceptorFigure 1. LRP4 Is Specifically Expressed in Myotubes and Concentrated at the NMJ
(A) Temporal expression pattern of LRP4 during muscle differentiation. C2C12 myoblasts were switched to the differentiation medium. Muscle cells were
collected at indicated times and lyzed. Lysates (30 mg of protein) were resolved by SDS-PAGE and visualized by immunoblotting using indicated antibodies.
(B) Colocalization of LRP4 with R-BTX in muscle sections. Diaphragm sections were incubated with polyclonal antibodies against LRP4 or MuSK, which were
visualized by Alexa Fluor 488-conjugated anti-rabbit antibody. R-BTX was included in the reaction to label postsynaptic AChRs. Arrows indicate colocalization
of LRP4 or MuSK with AChRs.
(C) Enrichment of LRP4 in synaptic regions of muscles. Synaptic (S) and nonsynaptic (NS) regions of hemidiaphragms were isolated and homogenized. Homog-
enates (30 mg of protein) were analyzed for LRP4 or AChR (as control) using specific antibodies. Samples were also probed for b-actin to indicate equal loading.respond to agrin. These observations identify LRP4 as a key
component of the receptor complex of agrin.
RESULTS
LRP4 Is Expressed Specifically in Myotubes
and Concentrated at the NMJ
Because neuronal agrin binds only to myotubes, but not myo-
blasts (Glass et al., 1996b), we characterized the expression of
LRP4 in developing myotubes. C2C12 myoblasts were switched
to fusion medium to induce muscle differentiation. Under these
conditions, myotubes began to form 48 hr after medium switch
(Luo et al., 2002, 2003; Si et al., 1996). Developing myotubes
were collected and LRP4 expression was analyzed by immuno-
blotting with anti-LRP4 antibody. As shown in Figure 1A, LRP4
was barely detectable in myoblasts, but its expression gradually
increased as myotubes matured. As a control, expression of
MuSK, whose expression was known to be regulated by muscle
differentiation (Glass et al., 1996b; Ip et al., 2000; Valenzuela
et al., 1995), was examined in the same preparations (Figure 1A).
These results indicate that LRP4, likeMuSK, is expressed inwell-
differentiated myotubes, but not myoblasts. Next, we investi-
gated LRP4 distribution in vivo by staining muscle sections with
anti-LRP4 antibody. The immunoreactivity of LRP4, as well as
that of MuSK, showed a pattern of labeling similar to that of rho-
damine-conjugated a-bungarotoxin (R-BTX) that labels AChRs
(Figures 1B), suggesting that LRP4, like MuSK, is enriched at286 Neuron 60, 285–297, October 23, 2008 ª2008 Elsevier Inc.the NMJ. This notion was supported by results from immunoblot
analysis of LRP4 expression in muscles. Hemidiaphragms were
divided into three regions: the central, narrow region, whereNMJs
are enriched, as the synaptic region; the region close to ligaments
to the ribs as the nonsynaptic region; and the middle in between.
The AChR was enriched in the synaptic, but not nonsynaptic,
region (Figure 1C). In agreement with results of immunostaining,
LRP4 was readily detectable in the synaptic region where AChRs
were enriched. However, little, if any, LRP4was found in the non-
synaptic region. Together these results demonstrated that LRP4
is specifically expressed inmyotubes and is enriched at theNMJ,
suggesting a role of LRP4 in NMJ formation.
The LRP4 Extracellular Domain Binds to Neuronal Agrin
Next, we determined whether agrin binds to LRP4. A secreted
form of neuronal agrin, Flag-nAgrin, was generated that com-
prised the C terminus of neuronal agrin fused with the Flag epi-
tope, and a secreted form of LRP4 (i.e., LRP4N-Myc), which
consisted of the LRP4 extracellular domain tagged by the Myc
epitope, was generated also. Flag-nAgrin was immobilized on
beads and incubated with LRP4N-Myc. As shown in Figure 2A,
LRP4N-Myc was precipitated with neuronal agrin, suggesting
that the two proteins interact in solution. In contrast, Flag-nAgrin
did not precipitate MuSKect-Myc, which consisted of the extra-
cellular region of the kinase (Figure 2B); this was in agreement
with previous findings that agrin and MuSK do not directly bind
to each other (Glass et al., 1996a). Moreover, Flag-nAgrin did not
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LRP4 as an Agrin Coreceptorinteract with LRP6N-Myc, which comprised Myc-tagged extra-
cellular domain of LRP6, a homologous member of the LRP fam-
ily whose extracellular structural organization resembles that of
LRP4 (Figure 2C). As a control, LRP6N-Myc was able to interact
with Wnt-1-HA when the two proteins were incubated together
(Figure 2D), indicating proper folding and specific binding of
LRP6N-Myc. Furthermore, LRP4N-Myc did not coprecipitate
with Wnt-1-HA (Figure 2E), suggesting that the two proteins do
not interact. These results demonstrate that agrin binds specifi-
cally to the extracellular domain of LRP4, but not that of MuSK or
LRP6; on the other hand, Wnt-1 interacts with LRP6, but not
LRP4. In support of this notion, the extracellular domain of LRP4
was able to neutralize neuronal agrin and thus prevent it from
stimulating MuSK tyrosine phosphorylation and AChR clustering
(Figure S1 available online).
To determine whether the interaction is direct, we produced
recombinant agrins, nAgrin-AP andmAgrin-AP, which contained
the C-terminal region of neuronal andmuscle agrin, respectively.
They were fused with the heat-insensitive human placental iso-
zyme of alkaline phosphatase (AP) (Flanagan and Cheng, 2000)
(Figure 3A). The activity of the AP recombinant proteins was
tested in AChR cluster assays. As shown in Figure 3B, nAgrin-
AP was able to stimulate AChR clustering in C2C12 myotubes,
indicating proper folding of the recombinant neuronal agrin pro-
tein. In contrast, mAgrin-AP or AP alone had little effect on AChR
clustering. Next, we characterized the binding activity of the AP
Figure 2. The LRP4 Extracellular Domain
Interacts with Neuronal Agrin
(A–C) Interaction of LRP4 and neuronal agrin in
solution. Beadswere conjugatedwith Flag-nAgrin,
and were subsequently incubated with condition
media of HEK293 cells expressing LRP4N-Myc
(A), MuSKect-Myc (B), LRP6N-Myc (C), or empty
vector (control). Bound proteins were isolated by
bead precipitation, resolved by SDS-PAGE, and
visualized by immunoblotting with anti-Myc anti-
body. Flag-nAgrin interacted with LRP4N-Myc
(A), but not MuSKect-Myc (B) or LRP6N-Myc (C).
(D) Interaction of Wnt-1 and LRP6N. Beads were
conjugated with Wnt-1-HA, and were subse-
quently incubated with LRP6N-Myc. Bound
LRP6N-Myc was revealed by immunoblotting.
(E) No interaction between Wnt-1 and LRP4N.
Beads were conjugated with Wnt-1-HA and were
subsequently incubated with LRP4N-Myc. Bound
LRP4N-Myc was revealed by immunoblotting.
Figure 3. High-Affinity and Specific Interac-
tion between LRP4 and Neuronal Agrin
(A) Schematic diagrams of AP constructs. Neuro-
nal or muscle agrin was fused to AP in pAPtag-5.
The fusion proteins contain a signal peptide (SS)
in the N terminus and two additional tags (Myc
and His) in the C terminus. Neuronal agrin contains
four and eight amino acid residue inserts at the
Y and Z sites, respectively.
(B) Functional characterization of agrin-AP re-
combinant proteins. C2C12 myotubes were stim-
ulated with AP alone, mAgrin-AP, or nAgrin-AP
for 18 hr. AChR clusters were assayed as de-
scribed in Experimental Procedures. Data shown
were mean ± SEM. n = 4; *p < 0.05 in comparison
with AP or mAgrin-AP.
(C) Differential binding activities of mAgrin-AP and
nAgrin-AP to myoblasts and myotubes. C2C12
myoblasts and myotubes were incubated in AP
alone, mAgrin-AP, or nAgrin-AP for 90 min at room
temperature. Endogenous AP was inactivated by
heating and bound AP was assayed by staining
with BCIP/NBT. Data shown were mean ± SEM.
n = 6; *p < 0.05.
(D) Direct interaction between LRP4 and neuronal agrin. LRP4-Myc was purified and coated on Maxi-Sorp Immuno Plates, which were incubated with nAgrin-AP
or mAgrin-AP. AP activity was measured with pNPP as substrate. Control, condition medium of HEK293 cells transfected with the empty pAPtag-5. Data shown
were mean ± SEM. n = 3; *p < 0.05 in comparison with AP or mAgrin-AP.
(E) Dose-dependent interaction between LRP4 and neuronal Agrin. Purified LRP4-Myc was coated on Maxi-Sorp Immuno Plates, which were incubated with
nAgrin-AP or mAgrin-AP. AP activity was measured with pNPP as substrate. Data shown were mean ± SEM. n = 4; *p < 0.05.
(F) Scatchard plot of data in (E). y axis represents the ratio of bound to free nAgrin-AP whereas x axis represents the amount of bound nAgrin-AP.Neuron 60, 285–297, October 23, 2008 ª2008 Elsevier Inc. 287
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perimental Procedures. AP binding to myoblasts or myotubes
was minimal (Figure 3C). mAgrin-AP binding to myoblasts was
higher than that of AP alone, presumably because myoblasts
express alpha-dystroglycan, with which muscle agrin is known
to interact (Bowe et al., 1994; Campanelli et al., 1994, 1996;
Gee et al., 1994; Gesemann et al., 1996; Hopf and Hoch, 1996;
Sugiyama et al., 1994). The mAgrin-AP binding to myotubes was
higher in comparison with that to myoblasts because alpha-
dystroglycan expression was increased during muscle differen-
tiation. nAgrin-AP binding to myoblasts was similar to that of
mAgrin-AP (Figure 3C). However, nAgrin-AP binding was sig-
nificantly higher in myotubes than in myoblasts (Figure 3C), in
agreement with earlier reports (Glass et al., 1996a) and the LRP4
expression pattern in developing muscle cells (Figure 1). These
results demonstrate the differential abilities of recombinant mus-
cle and neuronal agrins in binding to myotubes. Having estab-
lished that nAgrin-AP was able to bind to myotubes and stimu-
late AChR clustering, we next characterized the interaction
between LRP4 and nAgrin-AP. LRP4N-Myc was purified and im-
mobilized on plates and incubated with purified nAgrin-AP. After
washing, the AP activity bound to immobilized LRP4N-Myc was
assayed by a modified enzyme-linked immunosorbent assay
(ELISA). In comparisonwith control (AP alone), therewas a signif-
icant increase in AP activity when nAgrin-AP was incubated with
LRP4N-Myc (Figure 3D), suggesting direct interaction between
the two proteins, i.e., interaction independent of a third protein.
Quantitatively, the interaction between neuronal agrin and LRP4
was dose-dependent, saturable, and of high affinity (Kd values
of 0.5 ± 0.053 nM) (Figures 3E and 3F). This affinity is comparable
to that of LRP6 for Dkk1 and Dkk2 (0.1–0.5 nM) (Bafico et al.,
2001; Mao et al., 2001; Semenov et al., 2001). In contrast, mus-
cle agrin, which lacks four and eight amino acid inserts at the Y
and Z sites, respectively (Figure 3A), and is 1000 times less po-
tent than neuronal agrin in stimulating AChR clusters (Gesemann
et al., 1995; Reist et al., 1992), did not appear to bind to LRP4
(Figure 3D). The binding of LRP4N-Myc tomuscle agrin wasmin-
imal even at high concentrations (Figure 3E). Together, these re-
sults suggest LRP4 binds specifically to neuronal agrin with high
affinity. These results also indicate that LRP4 binds to neuronal,
but not muscle, agrin in a manner that is concentration depen-
dent, saturable, and of high affinity.
Reconstitution of Neuronal Agrin Binding and Signaling
in Transfected Cells
To determine whether agrin binds to LRP4 in vivo, we expressed
exogenous LRP4 in C2C12 myoblasts that, unlike myotubes, do
not bind neuronal agrin (Glass et al., 1996a) (Figure 3C). Myo-
blasts were transfectedwith full-length LRP4 or the empty vector
(as control). Intact transfected myoblasts were incubated with
AP alone, nAgrin-AP, or mAgrin-AP. The AP activity bound to
the cell surfacewasmeasured in situ after heat inactivation of en-
dogenous AP. As shown in Figures 4A and 4B, when incubated
with AP alone, control and LRP4-transfected myoblasts show no
difference in AP activity. However, nAgrin-AP binding to LRP4-
transfected myoblasts was significantly higher in comparison
with control, indicating that LRP4 enables myoblasts to interact
with neuronal agrin. By contrast, transfection of MuSK had288 Neuron 60, 285–297, October 23, 2008 ª2008 Elsevier Inc.no consistent effect on binding to nAgrin-AP, in agreement
with earlier observations that agrin does not bind toMuSK (Glass
et al., 1996a) (Figure 2B). In addition to myoblasts, HEK293
cells were able to bind to nAgrin-AP after LRP4 transfection
(Figure 4C).
The in situ binding activity generated by transfected LRP4 had
the following characteristics. First, it was dose dependent. An
increase in LRP4 expression in transfected HEK293 cells led to
higher nAgrin-AP binding activity (Figure 4C). Probably due to
rate-limiting surface integration of overexpressed LRP4, nAgrin-
AP binding was not further increased in cells transfected with
2 mg of DNA. Earlier studies have reported that overexpressed
LRP4 is retained in the endoplasmic reticulum (Obermoeller-
McCormick et al., 2001). Notice that the blot in Figure 4C reveals
total, but not surface, LRP4. Second, LRP4 binding was specific
for neuronal agrin because the amount of mAgrin-AP bound to
transfected myoblasts and HEK293 cells was minimal, and not
concentration dependent (Figures 4A–4C). Notice that mAgrin-
AP, like nAgrin-AP, also contained the AP and the Myc and His
tags. Inability of mAgrin-AP to bind to LRP4-transfected cells in-
dicated that binding to LRP4 did not involve the AP or tags. Third,
the binding activity was LRP4 specific. Expression of LRP5, an-
other member of the LRP family (Herz and Bock, 2002), did not
increase agrin binding in transfected cells (Figure 4D). Finally,
nAgrin-AP binding was similar between cells transfected with
LRP4 alone and those cotransfected with LRP4 and MuSK (Fig-
ures 4A and 4B), indicating that the neuronal agrin binding activ-
ity is mainly contributed by LRP4, although LRP4 and MuSK
could interact in muscle cells (see below). Taken together, these
results demonstrate the ability of LRP4 to reconstitute agrin
binding in cells that otherwise do not interact with agrin.
Next, we determined if LRP4 was able to reconstitute MuSK
signaling in cells that do not respond to agrin. MuSK is a receptor
tyrosine kinasewhose activation has been shown to be upstream
of all known agrin signaling cascades (Fuhrer et al., 1997; Glass
et al., 1996a, 1997; Herbst and Burden, 2000; Luo et al., 2002;
Strochlic et al., 2005;Wang et al., 2008; Zhou et al., 1999). There-
fore we first examined whether LRP4 expression enables MuSK
activation by agrin in HEK293 cells that do not express LRP4
(Figure 4E). Flag-MuSK was transfected into HEK293 cells with
or without LRP4, and transfected cells were stimulated with neu-
ronal agrin. As shown in Figures 4E and 4G, agrin was unable to
elicitMuSK tyrosine phosphorylation inHEK293 cells transfected
with MuSK alone. Intriguingly, LRP4 coexpression enabled agrin
to activateMuSK, indicating that LRP4could be an agrin receptor
able to stimulateMuSK.Basal tyrosinephosphorylation ofMuSK,
i.e., in the absence of agrin, was increased by LRP4, which could
suggest a role of LRP4 in MuSK autoactivation, presumably by
its direct interaction with the kinase (see below). Agrin-induced
AChR clustering requires the intracellular tyrosine kinase Abl
(Finn et al., 2003). To further investigate the role of LRP4, we
examined Abl activation by anti-phospho-Abl antibody in cells
coexpressing LRP4 and MuSK. As shown in Figures 4F and 4G,
active Abl was barely detectable in cells transfected with Myc-
MuSK alone, regardless of agrin stimulation. In contrast, agrin
elicited a significant increase in phospho-Abl in cells coexpress-
ing LRP4 and Myc-MuSK. Together, these results indicate that
LRP4 expression enables binding activity for neuronal agrin,
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LRP4 as an Agrin CoreceptorFigure 4. Expression of LRP4 Enables Binding Activity for Neuronal Agrin and MuSK Signaling
(A) Neuronal, but not muscle, agrin bound to intact C2C12myoblasts transfected with LRP4. C2C12myoblasts were transfected by empty vector (control), LRP4,
and/or Flag-MuSK. Thirty-six hours after transfection, myoblasts were incubated with AP alone, mAgrin-AP, or nAgrin-AP for ninetyminutes at room temperature.
Endogenous AP was inactivated by heating and bound AP was visualized in cells by staining with BCIP/NBT.
(B) Quantification of data in (A). Data shownweremean ± SEM. n = 6; *p < 0.05 in comparisonwithmAgrin-AP of the same group or nAgrin-AP in the control group.
(C and D) nAgrin-AP bound to HEK293 cells expressing LRP4, but not those expressing LRP5. HEK293 cells were transfected without (control) or with LRP4-Myc
(C) or LRP5-Myc (D). Thirty-six hours after transfection, transfected cells were incubated with nAgrin-AP or mAgrin-AP. In some experiments, control cells were
incubated with nAgrin-AP. After heat inactivation of endogenous AP, lysates were assayed for transfected AP using pNPP as substrate. Lysates were also
subjected to immunoblotting to reveal the expression of different amounts of LRP4-Myc (C) and LRP5-Myc (D). Data shown were mean ± SEM. n = 6.
(E and F) LRP4 expression enabled MuSK and Abl activation by agrin in HEK293 cells. Cells were transfected with LRP4 and/or Flag-MuSK (E) or Flag-Abl (F).
Thirty-six hours after transfection, cells were treated with or without neuronal agrin for one hour and were then lyzed. In (E), lysates were incubated with anti-Flag
antibody, and resulting immunocomplex was analyzed with anti-phosphotyrosine antibody 4G10. In (F), active Abl was revealed by immunoblotting with specific
phospho-Abl antibody. Lysates were also blotted for Flag and/or Myc, LRP4, or b-actin to indicate equal amounts of proteins.
(G) Quantitative analysis of data in (E) and (F). MuSK and Abl phosphorylation was quantified by using the ImageJ software. Data shown were mean ± SEM. n = 3;
*p < 0.05 in comparison with control.Neuron 60, 285–297, October 23, 2008 ª2008 Elsevier Inc. 289
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LRP4 as an Agrin CoreceptorFigure 5. Suppression of LRP4 Expression Attenuates Neuronal Agrin Binding, MuSK Activation, and Induced AChR Clustering
(A) Characterization of LRP4-miRNA constructs. HEK293 cells were transfected with LRP4 and LRP4-miLRP4 constructs or control miRNA that encoded scram-
bled sequence. Cell lysates were analyzed for LRP4 expression by immunoblotting with anti-LRP4 antibody. b-actin was used as loading control. miLRP4-1062
was most potent in inhibiting LRP4 expression.
(B) Repression of LRP4 expression reduced neuronal agrin binding to myotube surface. C2C12 myotubes were transfected with control (scramble) miRNA or
miLRP4-1062. Cells were incubated with AP, mAgrin-AP, or nAgrin-AP, which was visualized in cell as described in Figure 3A.
(C) Quantitative analysis of data in (B). Data shown were mean ± SEM. n = 6; *p < 0.05 comparing nAgrin-AP with control.
(D)MuSK activation by neuronal agrin was diminished in C2C12myotubes transfectedwithmiLRP4-1062. C2C12myotubes were transfectedwith controlmiRNA
or miLRP4-1062. Thirty-six hours later, myotubes were treated without or with agrin for one hour and cells were then lyzed. MuSK was isolated by immunopre-
cipitation and blotted with the anti-phosphotyrosine antibody 4G10. Lysateswere also blotted for MuSK, LRP4, GFP (encoded bymiRNA constructs), and b-actin
to indicate equal amounts of proteins.
(E) Quantitative analysis of data in (D) by ImageJ software (mean ± SEM, n = 3; *p < 0.05 in comparison with control).
(F) Neuronal-agrin-induced clustering of AChRs was inhibited in C2C12 myotubes transfected with miLRP4-1062. C2C12 myotubes were transfected by control
miRNA, miLRP4-1062, miMuSK-1161, or miLRP5-1490. AChR clusters were induced by neuronal agrin and quantified as described in Experimental Procedures
(mean ± SEM, n = 5; *p < 0.05 in comparison with control). miMuSK-1161 and miLRP5-1490 were able to suppress expression of respective proteins in
transfected cells (data not shown).MuSK activation, and initiation of intracellular signaling in cells
that otherwise do not respond to agrin.
Decrease of LRP4 Levels Attenuates Neuronal
Agrin Binding, MuSK Activation, and Induced
AChR Clustering in Muscle Cells
We next determined if LRP4 is necessary for agrin/MuSK signal-
ing by a loss-of-function approach. To this end, we generated
several microRNA constructs of LRP4. As shown in Figure 5A,
miLRP4-1062 was most potent in inhibiting LRP4 expression.
First, we determined if repression of LRP4 affects agrin binding
to intact muscle cells. C2C12 myoblasts were transfected with
miLRP4-1062 or the control miRNA that encoded scramble
sequence, and resulting myotubes were incubated with AP,
mAgrin-AP, or nAgrin-AP and assayed for AP activity by in-cell
staining. In comparison with control miRNA, miLRP4-1062 did
not appear to alter binding activity of AP and mAgrin-AP to
myotubes (Figures 5B and 5C). However, myotubes transfected290 Neuron 60, 285–297, October 23, 2008 ª2008 Elsevier Inc.withmiLRP4-1062 had lower levels of nAgrin-AP staining in com-
parison with those transfected with the control vector (Figures
5B and 5C), indicating a necessary role of endogenous LRP4
in neuronal agrin binding. Second, we tested whether LRP4 is re-
quired for agrin to stimulate tyrosine phosphorylation of MuSK.
MuSK was precipitated from myotubes transfected with control
miRNA or miLRP4-1062 and assayed for tyrosine phosphoryla-
tion. Expression of miRNA constructs was indicated by the pres-
ence of GFP that was encoded by the parental vector. As shown
in Figure 5D, transfection of miLRP4-1062 reduced expression
of endogenous LRP4, but not MuSK or b-actin. Remarkably, in
comparison with control miRNA, agrin-induced MuSK tyrosine
phosphorylation was attenuated in myotubes transfected with
miLRP4-1062 (Figure 5E). These results suggest that MuSK
activation was impaired when LRP4 levels were reduced.
Finally, we investigated whether LRP4 is necessary for agrin-
induced AChR clustering. Myoblasts were transfected with con-
trol miRNA or miLRP4-1062, or miRNA constructs against MuSK
Neuron
LRP4 as an Agrin CoreceptorFigure 6. Direct Interaction between LRP4
and MuSK
(A) Increased LRP4-MuSK interaction in the pres-
ence of neuronal agrin. Flag-MuSKect immobi-
lized on beads was incubated with condition me-
dia of cells expressing the extracellular domains
of LRP4 (LRP4N-Myc) or the empty vector (con-
trol) in the presence or absence of neuronal agrin.
Precipitated LRP4 was analyzed by immunoblot
with anti-Myc antibody. Reaction mixtures were
also blotted directly for Flag and Myc to demon-
strate equal amounts of proteins.
(B) Quantitative analysis of LRP4N-Myc and Flag-
MuSK. Data shown were mean ± SEM. n = 3; *p <
0.05 in comparison with the no-agrin group.
(C) Dose-dependent interaction between LRP4
and MuSK. Purified LRP4-Myc was coated on
Maxi-Sorp Immuno Plates, which were incubated
with MuSK-AP. Bound AP was measured with
pNPP as substrate. Data shown were mean ±
SEM. n = 4.
(D) Scatchard plot of data in (C). y axis represents
the ratio of bound to freeMuSK-AP whereas x axis
represents the amount of bound MuSK-AP.
(E) No interaction of LRP6 and MuSK extracellular
domains. Experiments were done as in (A), except
condition medium of cells expressing the extracel-
lular domain of LRP6 was used.
(F) Coimmunoprecipitation of LRP4 and MuSK.
HEK293 cells were transfected with LRP4, Flag-
MuSK, or both. Lysates were incubated with anti-
Flag antibody, and resulting immunocomplex
was analyzed for LRP4 and Flag. Lysates were
also probed to indicate equal amounts of indicated
proteins.
(G) Interaction of LRP4 with MuSK in mouse mus-
cles. Mouse muscles of indicated ages were
homogenized, and homogenates were incubated
with rabbit anti-LRP4 antibody or rabbit normal
IgG.Precipitateswere probed forMuSKandLRP4.
Homogenates were also probed directly forMuSK,
LRP4, and b-actin (bottom panels).and LRP5 that reduced expression of MuSK and LRP5, respec-
tively (data not shown). Transfected myotubes were stimulated
with or without agrin and AChR clusters in GFP-expressing my-
otubes and scored as described previously (Zhang et al., 2007).
Expression of these miRNA constructs did not appear to alter
basalAChRclusters.However, thenumberofagrin-inducedAChR
clusters was reduced in myotubes transfected with miLRP4-
1062 (Figure 5F), suggesting a necessary role of LRP4 in agrin-
induced clustering. Similar reduction was observed in myotubes
expressing miMuSK-1161, as expected. Transfection with
miLRP5-1490, however, had no effect on agrin-induced AChR
clustering, in agreement with the observation that LRP5 does
not bind to neuronal agrin (Figure 4D).
Interaction between LRP4 and MuSK
In a working model, LRP4 serves as a coreceptor that binds to
agrin and, together with MuSK, stimulates AChR clustering. To
examine the relationship among agrin, LRP4, and MuSK, we
determined whether LRP4 interacts with MuSK and if so, if the
interaction is regulated by agrin. Secreted Flag-MuSKect, whichcomprised the entire extracellular region of MuSK fused with the
Flag epitope, was incubated with LRP4N-Myc in the absence or
presence of agrin. Flag-MuSKect alone was able to coprecipi-
tate with LRP4N-Myc (Figures 6A and 6B), indicative of direct
binding between the extracellular domains of MuSK and LRP4.
Quantitatively, the interaction between MuSK and LRP4 was
dose dependent and saturable, and of high affinity (Kd values
of 0.45 ± 0.041 nM, Figures 6C and 6D). Interestingly, the amount
of LRP4 coprecipitated with Flag-MuSKect was increased by
agrin (Figures 6A and 6B). In contrast, as control, LRP6N-Myc
failed to coprecipitate with Flag-MuSKect regardless of the pres-
ence or absence of agrin (Figure 6E). These observations sug-
gest that LRP4 and MuSK form a complex in the absence of
the ligand agrin; however, agrin, via binding to LRP4, enhances
the LRP4-MuSK interaction. To test this hypothesis further, we
examined if full-length MuSK and LRP4 interact with each other
in cells. LRP4 and Flag-MuSK were cotransfected into HEK293
cells. MuSKwas precipitated from cell lysates by a Flag antibody
and the resulting immunocomplex was analyzed for LRP4. As
shown in Figure 6F, LRP4 coprecipitated with MuSK inNeuron 60, 285–297, October 23, 2008 ª2008 Elsevier Inc. 291
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LRP4 as an Agrin Coreceptortransfected cells, in support of the notion that the two proteins
interact in transfected cells. Moreover, the LRP4-MuSK associ-
ation was detectable in mouse muscle homogenates
(Figure 6G), suggesting in vivo interaction of the two proteins.
Neuronal Agrin Stimulates LRP4 Interaction with MuSK
and Tyrosine Phosphorylation
To further investigate the role of LRP4 in agrin signaling, we
examined whether the LRP4-MuSK interaction in muscle cells
is regulated by neuronal agrin. C2C12 myotubes were treated
without or with agrin for 1 hr. Myotubes were subjected to immu-
noprecipitation with anti-LRP4 antibody and resulting precipi-
tates were probed for MuSK. As shown in Figure 7A, MuSK
coprecipitated with LRP4 from cells in the absence of agrin, sug-
gesting basal interaction of the two proteins, in agreement with
in vitro binding results (Figures 6A–6D). The coprecipitation was
increased in agrin-stimulated myotubes (Figures 7A and 7B).
These observations indicate that LRP4 and MuSK form a com-
plex that is upregulated by agrin.
LRP4 has a large intracellular domain containing six tyrosine
residues. Recent evidence indicates that LRP4, immunopurified
from the brain, could be phosphorylated on serine residues pre-
sumably by CaMK II (Tian et al., 2006). Other members of the
LRP family, LRP5 and LRP6, become phosphorylated upon ac-
tivation of the Wnt canonical pathway (Ding et al., 2008). Unlike
LRP5 and LRP6, LPR4 has an NPXY motif in the intracellular
region that may be phosphorylated by a tyrosine kinase (Herz
and Bock, 2002). Having demonstrated that LRP4 interacts with
MuSK and that the interaction is enhanced by agrin, we deter-
mined whether LRP4 itself becomes phosphorylated on tyrosine
residues. C2C12 myotubes were stimulated with neuronal agrin
for 1 hr and lysates were subjected to immunoprecipitation of
LRP4 or MuSK. Resulting precipitates were probed with the
anti-phosphotyrosine antibody 4G10. As shown in Figures 7C
and 7D, LRP4 aswell asMuSK became tyrosine-phosphorylated
in agrin-stimulatedmyotubes. This result suggests a role of LRP4
in agrin signaling.
DISCUSSION
Major findings of this paper are as follows. First, LRP4 is specif-
ically expressed in myotubes, but not myoblasts, and is concen-
trated at the NMJ (Figure 1). Second, LRP4 is both necessary
and sufficient to bind to agrin and activate MuSK signaling,
which leads to AChR clustering. Using three different assays
(in solution, on solid phase, and in cells), we demonstrate that
neuronal agrin was able to interact directly with the extracellular
region of LRP4 (Figures 2, 3, and 4). The binding activity of LRP4
was specific because (1) LRP4 binding to muscle agrin was min-
imal; (2) the binding is concentration dependent and of high affin-
ity with a subnanomolar Kd; and (3) neuronal agrin did not bind to
LRP5 or LRP6, two other members of the LRP family that are
highly homologous to LRP4. Third, expression of LRP4 enabled
binding activity of neuronal agrin andMuSK signaling in cells that
otherwise did not respond to agrin (Figure 4). Fourth, suppres-
sion of LRP4 expression attenuated agrin binding activity and
agrin-induced MuSK phosphorylation and AChR clustering in
muscle cells (Figure 5). Fifth, LRP4 could interact with MuSK292 Neuron 60, 285–297, October 23, 2008 ª2008 Elsevier Inc.Figure 7. Agrin Stimulates the LRP4-MuSK Interaction and LRP4
Tyrosine Phosphorylation
(A) Agrin stimulated the interaction between endogenous LRP4 and MuSK.
C2C12 myotubes were stimulated with or without neuronal agrin. Lysates
were subjected to immunoprecipitation with rabbit anti-LRP4 antibody (top
panels) or rabbit normal IgG (middle panels). Resulting precipitates were
probed for MuSK or LRP4. Lysates were also probed with antibodies against
LRP4, MuSK, or b-actin to demonstrate equal amounts (bottom panels).
(B) Quantitative analysis of data in (A) by using the ImageJ software (mean ±
SEM, n = 3; *p < 0.05 in comparison with the no-agrin group).
(C) Agrin stimulated tyrosine phosphorylation of LRP4 in muscle cells. C2C12
myotubes were treatedwith or without agrin for 1 hr. Lysates were subjected to
immunoprecipitation with antibodies against LRP4 or MuSK. Resulting precip-
itates were probed with anti-phosphotyrosine antibody 4G10, or antibodies
against LRP4 or MuSK to indicate equal amounts of precipitated proteins.
(D) Quantitative analysis of data in (C). Data shown were mean ± SEM. n = 3;
*p < 0.05 in comparison with no-nAgrin group.
(E) A workingmodel. In the absence of neuronal agrin, LRP4 could interact with
MuSK and this interaction is increased by agrin stimulation. Such interaction is
necessary for MuSK activation and the downstream signaling that leads to
AChR clustering. P, phosphorylation.
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LRP4 as an Agrin Coreceptorin a manner that is increased by agrin (Figures 6 and 7). Finally,
LRP4 became tyrosine-phosphorylated in muscle cells in re-
sponse to agrin stimulation (Figure 7). These observations indi-
cate that LRP4 can bind to agrin and transmit signals to MuSK,
suggesting that it may serve as a functional receptor for agrin.
Based on these observations, we propose a working hypothesis
wherein LRP4 interacts with MuSK at basal levels in the absence
of the ligand. Upon agrin stimulation, the interaction was in-
creased to activate MuSK and subsequent downstream signal
cascades for AChR clustering (Figure 7E). Because mutations
and/or autoimmunization of agrin signaling proteins may cause
muscular dystrophies including myasthenia gravis and congeni-
tal myasthenic syndrome (Engel et al., 2008; Vincent and Leite,
2005), our results suggest that LRP4 may be a potential culprit
in these disorders.
Despite the essential role of MuSK in NMJ formation, mecha-
nisms of how it is activated and how it acts to control NMJ forma-
tion remain elusive. Recent studies have shed light on intracellu-
lar pathways downstream of MuSK. They are thought to involve
the adaptor protein Dok-7 (Okada et al., 2006) and several en-
zymes including Src-family kinase (Ferns et al., 1996; Mittaud
et al., 2001; Mohamed et al., 2001; Qu and Huganir, 1994; Wal-
lace, 1991), Abl (Finn et al., 2003), casein kinase 2 (Cheusova
et al., 2006), geranylgeranyl transferase I (GGT) (Luo et al., 2003),
GTPases of the Rho family (Weston et al., 2000, 2003), and Pak1,
a serine/threonine kinase that is activated by Rho GTPases (Luo
et al., 2002). Although agrin is known to activate MuSK, the two
proteins, however, do not interact directly. The MASC corecep-
tor that was hypothesized had to be myotube-specific and able
to transmit signal from agrin to MuSK (Glass et al., 1996a). Re-
markably, LRP4 is a protein specifically expressed in myotubes,
not inmyoblasts (Figure 1), fulfilling a requirement ofMASC. Sec-
ond, LRP4 is able to reconstitute agrin binding andMuSK signal-
ing in cells that otherwise do not respond to agrin (Figure 4).
Third, LRP4 is required for agrin binding and induced MuSK sig-
naling and AChR clustering in muscle cells (Figure 5). Fourth,
genetic studies have demonstrated that phenotypes of LRP4
mutant mice are similar to those in MuSK mutant (Weatherbee
et al., 2006). LRP4 mutants die at birth with defects in both pre-
synaptic and postsynaptic differentiation, and in particular, the
rapsyn-dependent scaffold fails to assemble in LRP4 mutants.
These results provide strong evidence that LRP4 satisfies the
essential criteria of a functional coreceptor of agrin.
The identification of LRP4 as a coreceptor for agrin could pro-
vide insight into mechanisms of how agrin stimulation leads to
AChR clustering. First, bridging agrin and MuSK, LRP4 could
transmit signal to MuSK and thus activate intracellular cascades
that have been identified, leading to AChR clustering. Second,
LRP4 may regulate MuSK activity. MuSK and LRP4 coprecipi-
tate in vitro and in muscle cells in the absence of agrin (Figures
6 and 7), and tyrosine phosphorylation of MuSK is increased in
cells coexpressing LRP4 (Figures 4E and 4G). These observa-
tions may suggest that LRP4 promotes MuSK autoactivation,
presumably by regulating MuSK dimerization. Exactly how LRP4
regulates MuSK function and the stoichiometry of the LRP4-
MuSK interaction warrant further investigation. Third and alter-
natively, LRP4 itself may function as a signal transducer. The
juxtamembrane cytoplasmic region of LRP4 contains a NPXYmotif. This motif in LDLR, LRP1, and LRP2 has been shown to
serve as a docking site for cytoplasmic adaptor proteins through
a phosphotyrosine binding (PTB) domain (Herz and Bock, 2002).
Intriguingly, LRP4 becomes tyrosine phosphorylated upon agrin
stimulation (Figures 7C and 7D). It would be interesting to inves-
tigate whether tyrosine phosphorylation of LRP4 is necessary
for agrin signaling and AChR clustering and whether phosphory-
lated LRP4 binds to PTB-domain-containing proteins. One such
protein is Dok-7, which is essential for NMJ formation (Okada
et al., 2006).
Wnt signaling is implicated in synapse formation (Ciani and
Salinas, 2005). Wnt-7a released from granule cells induces axon
and growth cone remodeling in mossy fibers (Hall et al., 2000). In
C. elegans, Wnt signaling positions NMJs by inhibiting synapto-
genesis (Klassen and Shen, 2007). NMJ formation in Drosophila
requiresWnt signaling (Mathewet al., 2005; Packard et al., 2002).
However, it remains unclear whether Wnt signaling regulates
mammalian NMJ formation. Wnt ligands act by binding to the re-
ceptor complex of Frizzled and LRP5/6 (Cadigan and Liu, 2006;
He et al., 2004; Malbon and Wang, 2006; Schulte and Bryja,
2007). Subsequently, signal is believed to be transmitted to the
adaptor protein Dishevelled (Dvl), which interacts with Frizzled,
to initiate intracellular canonical and noncanonical pathways. In-
triguingly, MuSK, like Frizzled, interacts with both an LRP protein
(i.e., LRP4) and Dvl (Luo et al., 2002). In addition, MuSK contains
an extracellular CRD domain that is highly homologous to that in
Frizzled that interacts with Wnt (Glass et al., 1996a; Valenzuela
et al., 1995). Moreover, a number of Wnt signaling molecules
including APC and b-catenin have been implicated in MuSK
cascades (Li et al., 2008; Wang et al., 2003; Zhang et al.,
2007). These observations raise the question of whether agrin-
LRP4-MuSK signaling is regulated by aWnt ligand thatmay inter-
act with LRP4 and/or MuSK. We showed that LRP4 does not
bindWnt-1 (Figure 2E). This, however, does not exclude possible
involvement of 1 of the 18 other Wnt proteins in mouse (Clevers,
2006) (The Wnt Homepage: www.stanford.edu/rnusse/
wntwindow). On the other hand, the Wnt signaling molecules (in-
cludingDvl, APC, and b-catenin)may simply function in amanner
independent of Wnt signaling in mammalian NMJ formation.
It is of interest to note that the phenotypes of MuSK and LRP4
mutantmice aremore severe than those of agrin mutant. In LRP4
or MuSK mutants, but not agrin mutants, AChR clusters are ab-
sent when clusters begin to assemble at E13.5, and the rapsyn-
dependent scaffold fails to assemble (Lin et al., 2001; Weather-
bee et al., 2006). These observations could suggest the existence
of a signaling pathway that requires MuSK and/or LRP4, but not
agrin. This pathway may regulate the formation of aneuronal
AChR clusters prior to the arrival of motoneuron terminals or the
assembly of the rapsyn-dependent scaffold. It may be regulated
by a ligand that could interact with MuSK and/or LRP4. In light of
the above discussion, such a ligand may be a Wnt protein.
Agrin is expressed in the brain (Cohen et al., 1997; Mann and
Kroger, 1996; O’Connor et al., 1994). Suppression of its expres-
sion impairs dendritic development and synapse formation in
cultured hippocampal neurons (Bose et al., 2000; Ferreira, 1999).
Agrin-deficient neurons appear to be resistant to excitotoxic
injury and agrin heterozygous mice are less sensitive to kainic-
acid-induced seizure and mortality (Hilgenberg et al., 2002).Neuron 60, 285–297, October 23, 2008 ª2008 Elsevier Inc. 293
Neuron
LRP4 as an Agrin CoreceptorAgrin is thought to bind to the a3 subunit of Na+/K+-ATPase in
neurons and thus regulates their function (Hilgenberg et al.,
2006). LRP4 expression is enriched in the brain and could inter-
act with postsynaptic scaffold proteins including PSD-95 and
SAP97 (Lu et al., 2007; Tian et al., 2006;Weatherbee et al., 2006).
The identification of LRP4 as a coreceptor of neuronal agrin may
shed light on molecular mechanisms that underlie how agrin and
LRP4 work in the brain.
EXPERIMENTAL PROCEDURES
Reagents and Antibodies
Taq DNA polymerase, T4 DNA ligase, and restriction enzymeswere purchased
from Promega. Horseradish peroxidase conjugated goat anti-mouse and goat
anti-rabbit antibodies and enhanced chemifluoresent (ECL) reagents forWest-
ern blotting were fromAmersham. Rhodamine-aBTX (R-BTX) was fromMolec-
ular Probes. Oligonucleotides were synthesized by Operon Biotechnologies.
Unless otherwise specified, all chemicals were fromSigma-Aldrich. Antibodies
were purchased from Sigma (Flag M2, F3165); Torrey Pines Biolabs (GFP,
TP401); Upstate Biotechnology (4G10, 05-1050); Cell Signaling (Phospho-c-
Abl, 2861); Novus (b-actin, NB600-501). Rabbit anti-MuSK antibodies were
described previously (Luo et al., 2002). Rabbit anti-LRP4 antibody was de-
scribed previously (Lu et al., 2007). Rat anti-AChR a-subunit (mAb35) antibody
was a gift from Dr. Richard Rotundo. Rat anti-AChR b-subunit (mAb124) anti-
body was a gift from Dr. Jon Lindstrom.
Constructs
Original agrin constructs were gifts from Zach Hall. Agrin-AP constructs were
generatedby fusing neuronal andmuscle agrin (amino acids 1379–1940) (Ferns
et al., 1993) with AP in pAPtag-5. To generate Flag-MuSK, the MuSK DNAwas
generated by PCR and subcloned in EcoRI/XbaI sites in pFlag-CMV1 down-
stream of an artificial signal peptide sequence and a Flag epitope. LRP4-Myc
was generated by subcloning the full-length LRP4 DNA into NheI and HindIII
sites in pcDNA3.1-MycHis (Invitrogen) with a three-alanine insert after amino
acid 1746. LRP4N-Myc was generated by subcloning LRP4 extracellular do-
main DNA into NheI andNotI sites in pcDNA3.1-MycHis. LRP5DNAwas ampli-
fied with pCMV-Sports6-LRP5 (Open Biosystems) as template and subcloned
into XbaI and NotI sites in pcDNA3.1-MycHis to generate LRP5-Myc. LRP4-,
LRP5-, and MuSK-miRNA constructs were generated using the BLOCK-iT
Pol II miR RNAi Expression Vector Kit (Invitrogene, K4936-00). Oligonucleotide
sequences for miRNA constructs wereas follows: for miMuSK-1161: 50-
TGCTGTAACACAGCAGAGCCTCAGCAGTTT TGGCCACTGACTGACTGCTG
AGGCTGCTGTGTTA-30 (sense), 50-CTGTAACACAGCAGCCTCAGCAGTCA
GTCAGTGGCCAAAACTGCTGAGGCTCTGCTGTGTTAC-30 (antisense); for
miLRP5-1490: 50-TGCTGATCACAGGGTGCAACACAATGGTTTTGGCCACTG
ACTGACCATTGTGTCACCCTGTGAT-30 (sense), 50-CCTGATCACAGGGTG
ACACAATGGTCAGTCAGTGGCCAAAACCATTGTGTTGCACCCTGTGATC-30
(antisense); for miLRP4-1062: 50-TGCTGTTAACATTGCAGTTCTCCTCAGTTT
TGGCCACTGACTGACTGAGGAGATGCAATGTTAA-30 (sense), 50-CCTGTTA
ACATTGCATCTCCTCAGTCAGTCAGTGGCCAAAACTGAGGAGAACTGCAAT
GTTAAC-30 (antisense); for miLRP4-2603: 50-TGCTGAATACATGTACCCGC
CCATGGGTTTTGGCCACTGACTGACCCATGGGCGTACATGTATT-30 (sense),
50-CCTGAATACATGTACGCCCATGGGTCAGTCAGTGGCCAAAACCCATGGG
CGGGTACATGTATTC-30 (antisense); for miLRP4-5355: 50-GCTGTAGCAC
AGCTGATTATACACGGTTTTGGCCACTGACTGACCGTGTATACAGCTGTGC
TA-30(sense), 50-CCTGTAGCACAGCTGTATACACGGTCAGTCAGTGGCCAA
AACCGTGTATAATCAGCTGTGCTAC-30 (antisense). The authenticity of all
constructs was verified by DNA sequencing. The following constructs were
described previously: MuSK-AP (Wang et al., 2008); pcDNA-LRP4 (Lu et al.,
2007); Wnt-1-HA (Zhang et al., 2007); andWnt-1-Myc and LRP6N-Myc (Tamai
et al., 2000).
Cell Culture and Transfection
HEK293 cells and mouse C2C12 muscle cells were maintained and trans-
fected as previously described (Zhang et al., 2007). In some experiments,294 Neuron 60, 285–297, October 23, 2008 ª2008 Elsevier Inc.myotubes were transfected with lipofectamine 2000 (Invitrogen, 11668-019).
The cells were incubated with a mixture of DNA, lipofectamine, and serum-
free medium for 8 hr before being switched to the fusion medium. The DNA:
lipofectamine ratio in the mixture was (1 mg):(2 ml). The optimal volume of the
mixture for 24-well dishes was 200 ml per well with 2 mg plasmid DNA.
Recombinant Protein Production and Purification
To produce recombinant proteins, HEK293 cells were transfectedwith respec-
tive plasmids. Twenty-four hours after transfection, cells were switched to Dul-
becco’s Modified Eagle Medium supplemented with reduced concentration
(0.05%) of fetal bovine serum, and secreted proteins were harvested 24 hr
later. nAgrin-AP, mAgrin-AP, or MuSK-AP recombinant proteins, which con-
tained 6-His-tags that were encoded by pAPtag-5, were purified by affinity
chromatography using TALON Resins (BD Biosciences).
Binding Assays
Solution Binding Assay
Flag-nAgrin was immobilized to protein A Sepharose beads (which were pre-
absorbed with anti-Flag antibody), which were incubated with 1 ml (0.5 nM) of
LRP4N-Myc, MuSKect-Myc, or LRP6N-Myc condition medium, and Flag-
nAgrin-bound proteins were isolated by bead precipitation, resolved by
SDS-PAGE, and visualized by immunoblot with anti-Myc antibody. In some
experiments, LRP4N-Myc, LRP6N-Myc, or MuSKect-Myc was incubated with
Wnt-1-HA immobilized on beads. LRP4 and LRP6 that were coprecipitated
with Wnt-1 were analyzed by immunoblot with anti-Myc antibody.
Solid Phase Binding Assay
Maxi-Sorp Immuno Plates (Nunc) were coated with purified LRP4-Myc at 4C
overnight, and then incubated with 1% BSA in PBS to block nonspecific bind-
ing. Coated wells were incubated with purified AP fusion proteins and the AP
activity was measured using p-nitrophenyl phosphate (pNPP) as substrate.
Intact Cell Binding Assays
Live C2C12 myoblasts or myotubes in 15 mm dishes were incubated at room
temperature for 90 min with 500 ml of 5 nM nAgrin-AP, mAgrin-AP, or AP. Cells
were washed three times with the HABH buffer (0.5 mg/ml bovine serum albu-
min, 0.1% NaN3, and 20 mMHEPES [pH 7.0] in Hank’s balanced salt solution)
and fixed in 60% acetone and 3% formaldehyde in 20 mM HEPES (pH 7.0) for
15s. Fixedcellswerewashedonce in 20mMHEPES (pH7.0) and150mMNaCl,
incubated at 65C for 100 min to inactivate endogenous AP, washed again in
the AP buffer (0.1 M Tris-HCl [pH 9.4]/0.1 M NaCl/5 mM MgCl2), and stained
at room temperature overnight with 5-bromo-4-chloro-3-indolyl-phosphate
(BCIP) (165 mg/ml)/nitroblue tetrazolium (NBT) (330 mg/ml) in the AP buffer. Dig-
ital photographs of stained cells were analyzed by using the NIH ImageJ soft-
ware. In some experiments, Agrin-AP-bound cells were lyzed in the lysis buffer
(1% Triton X-100 and 10 mM Tris [pH 8.0]). After the inactivation of the endog-
enous AP, lysates were assayed for AP activity using pNPP as substrate.
Immunoprecipitation, Immunoblotting, and AChR Clustering Assays
These assays were performed as previously described (Luo et al., 2002; Zhang
et al., 2007; Zhu et al., 2008). Unless otherwise indicated, the final concentra-
tion of recombinant neuronal agrin was 1 nM to stimulate muscle cells. Band
intensity of immunoblot was analyzed by using the ImageJ software.
Statistical Analysis
Data of multiple groups was analyzed by ANOVA, followed by a student-New-
man-Keuls test. Two-tailed Student’s t test was used to compare data be-
tween two groups. Differences were considered significant at p < 0.05. Values
and error bars in figures denote mean ± SEM.
SUPPLEMENTAL DATA
The supplemental data for this article include one supplemental figure and can
be found at http://www.neuron.org/supplemental/S0896-6273(08)00849-0.
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